Alternate site health provider Option Care Health (NASDAQ: OPCH) will be announcing earnings results this Wednesday morning. Here’s what to look for.
Option Care Health missed analysts’ revenue expectations last quarter, reporting revenues of $1.35 billion, up 1.3% year on year. It was a slower quarter for the company, with full-year revenue guidance missing analysts’ expectations significantly and full-year EBITDA guidance meeting analysts’ expectations.
Is Option Care Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Option Care Health’s revenue to be flat year on year, slowing from the 15.4% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Option Care Health rarely misses Wall Street’s revenue estimates.
Looking at Option Care Health’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 6.8%, beating analysts’ expectations by 3.9%, and UnitedHealth reported flat revenue, topping estimates by 1.2%. Tenet Healthcare traded up 17.2% following the results while UnitedHealth was also up 1.8%.
Read our full analysis of Tenet Healthcare’s results here and UnitedHealth’s results here.
Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices up 1.9% on average over the last month. Option Care Health is up 1.5% during the same time and is heading into earnings with an average analyst price target of $28.08 (compared to the current share price of $21.65).
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
